Cladis Investment Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$927K Hold
3,650
0.43% 66
2026
Q1
$892K Buy
3,650
+1
+0% +$233 0.49% 66
2025
Q4
$755K Hold
3,649
0.41% 73
2025
Q3
$677K Hold
3,649
0.39% 74
2025
Q2
$557K Hold
3,649
0.35% 79
2025
Q1
$605K Sell
3,649
-149
-4% -$23.3K 0.44% 71
2024
Q4
$549K Sell
3,798
-556
-13% -$86.2K 0.39% 72
2024
Q3
$706K Buy
4,354
+125
+3% +$19.9K 0.49% 62
2024
Q2
$618K Buy
4,229
+66
+2% +$9.82K 0.45% 66
2024
Q1
$659K Sell
4,163
-470
-10% -$74.8K 0.48% 65
2023
Q4
$726K Buy
4,633
+150
+3% +$23K 0.57% 55
2023
Q3
$698K Sell
4,483
-100
-2% -$16.5K 0.61% 54
2023
Q2
$759K Buy
4,583
+26
+0.6% +$4.2K 0.66% 51
2023
Q1
$706K Buy
4,557
+390
+9% +$63K 0.63% 54
2022
Q4
$736K Hold
4,167
0.73% 42
2022
Q3
$681K Buy
+4,167
New +$705K 0.74% 46
2022
Q1
Sell
-3,216
Closed -$550K 154
2021
Q4
$550K Buy
+3,216
New +$527K 0.44% 68

Other funds holding JNJ

Cladis Investment Advisory's JNJ Position: Q2 2026 in Review

Cladis Investment Advisory held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 3,650 shares worth $927K. The position accounts for 0.43% of the portfolio, ranked #66.

Cladis Investment Advisory first reported a position in JNJ in Q4 2021 and has held it in 17 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cladis Investment Advisory held 3,650 shares of Johnson & Johnson worth $927K as of Q2 2026.
  • Cladis Investment Advisory left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.43% of Cladis Investment Advisory's portfolio in Q2 2026, its #66 holding.
  • Cladis Investment Advisory first reported a position in Johnson & Johnson in Q4 2021 and has held it in 17 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cladis Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.